not an altogether unexpected reaction from the investment community but as a somewhere who sees this company as a very long term investment opportunity, I was happy, and was again impressed by the new MD.
I think the market didn’t like the customer power at play.
- Rebates up from 8 to 10%.
- Terms for customers being extended
- home branding impacting some lines (4mil impact)
- customers de-stocking (5mil impact apparently)
- the new deals sound like they are beneficial to customers in the short term (at the expense of GUD) with benefit to gud in the medium to longer term.
- new filter competition (bmc?), preventing price rises for RYco.
- gross margin pressure due to fx
- lower cash conversion due to investments in nwc
but having said all that there were certainly some positives:
- i think clearly their financing terms will be unibail-esque as I’m sure banks will be throwing money at them with rates where they are.
- They feel that home branding has reached a floor
- cash conversion guidance sounds very conservative
- Davey growing with volume, and price increases to come. High demand for some products.
- plenty of acquisition opportunities
- tailwinds from an extra 5 months of AAG this year.
And then the all important valuation...
With ebit growth forecast the company has a prospective ev/ebit of about 11 which seems excellent for a cash generative company that when all manner is going against them they still manage to report earnings growth. Net debt:ebitda is low and we can obviously expect bolt-ons in the near term.
To me the result seemed resilient and I’m a happy shareholder. If the market wants to have a short term hissy fit, then I’ll be waiting.
- Forums
- ASX - By Stock
- AOV
- Ann: Full Year Statutory Accounts
AOV
amotiv limited
Add to My Watchlist
3.36%
!
$8.62

Ann: Full Year Statutory Accounts, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$8.62 |
Change
0.280(3.36%) |
Mkt cap ! $1.170B |
Open | High | Low | Value | Volume |
$8.37 | $8.70 | $8.36 | $2.389M | 277.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 60 | $8.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$8.70 | 500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 60 | 8.520 |
1 | 1877 | 8.500 |
1 | 1184 | 8.440 |
1 | 6500 | 8.300 |
1 | 5000 | 8.260 |
Price($) | Vol. | No. |
---|---|---|
8.700 | 500 | 1 |
8.730 | 950 | 1 |
8.760 | 2000 | 1 |
8.850 | 2000 | 1 |
8.930 | 1100 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
AOV (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online